Cargando…
Economic burden of varicella in Europe in the absence of universal varicella vaccination
BACKGROUND: Though the disease burden of varicella in Europe has been reported previously, the economic burden is still unknown. This study estimated the economic burden of varicella in Europe in the absence of Universal Varicella Vaccination (UVV) in 2018 Euros from both payer (direct costs) and so...
Autores principales: | Pawaskar, Manjiri, Méroc, Estelle, Samant, Salome, Flem, Elmira, Bencina, Goran, Riera-Montes, Margarita, Heininger, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690977/ https://www.ncbi.nlm.nih.gov/pubmed/34930179 http://dx.doi.org/10.1186/s12889-021-12343-x |
Ejemplares similares
-
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization
por: Riera-Montes, Margarita, et al.
Publicado: (2017) -
Clinical and economic impact of universal varicella vaccination in Norway: A modeling study
por: Pawaskar, Manjiri, et al.
Publicado: (2021) -
The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia
por: Burgess, Colleen, et al.
Publicado: (2022) -
Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis
por: Vandenhaute, Jessica, et al.
Publicado: (2021) -
Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
por: Pawaskar, Manjiri, et al.
Publicado: (2022)